Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 76,940 | 50,107 | 39,516 | 18,838 | 24,393 |
| Marketable Securities | 104,146 | 78,996 | 72,115 | 96,322 | 97,246 |
| Receivables | 1,809 | 1,903 | 22,397 | 2,912 | 3,281 |
| Other current assets | 2,079 | 1,470 | 2,098 | 1,966 | 1,664 |
| TOTAL | $184,974 | $132,476 | $136,126 | $120,038 | $126,584 |
| Non-Current Assets | |||||
| PPE Net | 1,837 | 1,586 | 1,687 | 1,263 | 1,309 |
| Investments And Advances | 19,024 | 0 | 5,087 | 0 | 0 |
| Other Non-Current Assets | 4,306 | 4,306 | 6,128 | 6,104 | 6,104 |
| TOTAL | $25,167 | $5,892 | $12,902 | $7,367 | $7,413 |
| Total Assets | $210,141 | $138,368 | $149,028 | $127,405 | $133,997 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 596 | 1,111 | 766 | 932 | 507 |
| Accrued Expenses | 6,967 | 8,451 | 7,562 | 7,314 | 5,887 |
| TOTAL | $36,631 | $47,110 | $48,444 | $49,990 | $49,028 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 28,799 | 37,284 | 38,512 | 39,740 | 39,933 |
| Other Non-Current Liabilities | 2,004 | 1,925 | 1,822 | 1,729 | 1,613 |
| TOTAL | $29,676 | $31,177 | $42,835 | $51,857 | $61,975 |
| Total Liabilities | $66,307 | $78,287 | $91,279 | $101,847 | $111,003 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 66,307 | 66,240 | 55,257 | 55,239 | 55,201 |
| Common Shares | 66 | 55 | 55 | 55 | 55 |
| Retained earnings | -725,584 | -724,698 | -726,029 | -757,411 | -759,387 |
| Other shareholders' equity | -127 | -87 | -159 | -19 | -50 |
| TOTAL | $143,834 | $60,081 | $57,749 | $25,558 | $22,994 |
| Total Liabilities And Equity | $210,141 | $138,368 | $149,028 | $127,405 | $133,997 |